A detailed history of Legato Capital Management LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Legato Capital Management LLC holds 45,830 shares of PRCT stock, worth $3.84 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
45,830
Previous 51,670 11.3%
Holding current value
$3.84 Million
Previous $3.16 Million 16.32%
% of portfolio
0.48%
Previous 0.44%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$56.31 - $84.99 $328,850 - $496,341
-5,840 Reduced 11.3%
45,830 $3.67 Million
Q2 2024

Jul 26, 2024

BUY
$45.73 - $69.19 $443,626 - $671,212
9,701 Added 23.11%
51,670 $3.16 Million
Q4 2023

Jan 16, 2024

BUY
$24.89 - $43.41 $352,442 - $614,685
14,160 Added 50.92%
41,969 $1.76 Million
Q3 2023

Oct 12, 2023

BUY
$30.02 - $38.81 $834,826 - $1.08 Million
27,809 New
27,809 $912,000
Q2 2023

Aug 17, 2023

BUY
$26.7 - $37.02 $180,759 - $250,625
6,770 New
6,770 $239,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.73B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.